Gentris Corp. has entered an exclusive 10-year licensing agreement with Falco Biosystems, Ltd. medical testing laboratories in Japan. The agreement establishes Japan’s first GLP-compliant pharmacogenomics laboratory. The partnership, to be called “Gentris Japan,” will offer pharmacogenomics services to the pharmaceutical industry in Japan, the second-largest pharmaceutical market in the world after the U.S. “It is evident that pharmacogenomics is going to be as important...